Sarah Cannon Transplant & Cellular Therapy Program at St. David’s South Austin Medical Center
Locations
Transplant Summary
Overview
St. David’s South Austin Medical Center, which is part of St. David’s HealthCare, is a 368-bed acute care facility offering a range of complex specialties and sub-specialties, including a nationally accredited oncology program with the area’s only adult Transplant and Cellular Therapy Program; a trauma program that includes a Level II trauma center, with a dedicated Shock Trauma Intensive Care Unit, to treat the most severely injured and critical patients; comprehensive cardiac, stroke and orthopedic programs; full-service maternity and newborn care; robotic services; and two full-service emergency centers in the communities of Bee Cave and Bastrop.This center has been performing allogeneic transplants since 2014 and has been an NMDP transplant center since December 2023.
Attending physicians
Adult - Faheem Ahmed, Shahbaz Malik, Aravind Ramakrishnan, Uttam RaoTransplants performed
Marrow/PBSC onlyCord blood transplants
Not performedOther programs and services
Social workers conduct patient psychological assessments prior to transplant, and continue to support each patient throughout the transplant process. The outpatient social worker is a Licensed Clinical Social worker. An additional Licensed Master Social Worker is dedicated to our inpatient unit. Clinically trained and Board-Certified chaplains provide spiritual care and emotional support. Consultation services of a psychologist are available when additional and more intensive therapy needs are identified. Special emphasis is placed on evaluating and providing age specific patient support.
All program resources are available to the patient and family throughout their transplant journey, from referral through long-term follow up post transplant. In addition to the social workers, and chaplains, additional available resources available to patients include dieticians, financial coordinators, and local support groups.
- We are a member of the Sarah Cannon Transplant & Cellular Therapy Network that provides a network of colleagues focused on improving quality for patients across the country within our 7 transplant and cellular therapy programs.
_ patients have a dedicated coordinator throughout their transplant continuum.
- We provide a fully supported outpatient transplant and cellular therapy service
- Two dedicated TCT Pharmacists - PharmD, BCPS certified
- All infusion RNs have chemotherapy provider cards from the Oncology Nursing Society.
- 9 RNs are certified in oncology (OCN).
- 7 RNs with BMTCN certification
- Apheresis Collection Center
- Photopheresis Services
- Clinical Research trials through the Sarah Cannon Research Institute.Patient survival information for this center
This center's actual 1-year survival results are similar to the expected rate for this center*.The survival information we have for this center includes ONLY:- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2020, 2021, 2022 and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 114 patients.The actual 1-year survival of these patients is 83.3%.Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 70.2% and 85%.For help with understanding these statistics, please see Understanding Transplant Outcomes.For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report (Opens in a new tab) at bloodcell.transplant.hrsa.gov.* The expected survival rate for a transplant center can be below, similar to, or above the range listed. This is based on comparing patient survival at all centers that treated patients with similar diseases.
The survival rate cannot tell how you will do with your transplant. Talk to your doctor to understand your prognosis or the likely course of your disease.
Total adult transplants
280
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total AllogeneicRelated donorMarrow2PBSC30Cord blood0Total32Unrelated donorMarrow1PBSC59Cord blood0Total60Total allogeneicMarrow3PBSC89Cord blood0Total92AutologousMarrowBoth marrow & PBSC 188PBSC—Cord blood—Total188Total combinedMarrowBoth marrow & PBSC 280PBSC—Cord blood0Total280All Diseases
Number of transplants by age reported from January 1, 2022 to December 31st, 2023(includes marrow, PBSC and cord blood)
0-18 19-44 45-64 65+ Total Related 0-18019-441345-641765+2Total32Unrelated 0-18019-441145-642965+20Total60Autologous 0-18019-441845-649265+78Total188Total 0-18019-444245-6413865+100Total280Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants can be found:
- U.S. Transplant Data by Center (Opens in a new tab) report at blood cell.transplant.hrsa.gov
- List of diseases
Transplant center resources
NMDP patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
- Inside the United States: 1 (888) 999-6743
- Outside the United States: 1 (763) 406-3410. (Long distance or international charges may apply.)
Email: patientinfo@nmdp.org
More resources
- Choosing a transplant center
- Preparing for transplant
- Learn about transplant outcomes and treatment decisions (Opens in a new tab)
- Support and resources (including non-English materials)
- U.S. Transplant Data by Center (Opens in a new tab) at blood cell.transplant.hrsa.gov
No survivorship program information is available. Contact the center for information about post-transplant care.